Kovina Therapeutics, whose CEO is Kristin Sherman, is starting out in the lab of Dr. Elliot Androphy, right, former chair of the IU School of Medicine’s department of dermatology. The firm received ...

This post is sponsored by BioCrossroads. BioCrossroads announced today the formation of the Indiana Seed Fund II (the Fund), an early-stage capital fund focused on identifying, creating and developing ...

INDIANAPOLIS, Sept. 26, 2019 /PRNewswire/ -- Today at the Indiana Life Sciences Summit, BioCrossroads' Board of Directors named Dr. Clem J. McDonald recipient of the 2019 August M. Watanabe Life ...

INDIANAPOLIS, Oct. 10, 2018 /PRNewswire/ -- BioCrossroads today announced the formation of its $9 million Indiana Seed Fund III at its Indiana Life Sciences Summit. The Indiana Seed Fund III is an ...

In the decade since the state’s biggest public and private institutions decided to join forces to promote the life sciences industry—organized under the group BioCrossroads—the effort has achieved ...

INDIANAPOLIS, Ind., Sept. 26, 2016 — The fifth annual BioCrossroads New Venture Competition, an early stage business competition, has uncovered several promising life sciences and health information ...

INDIANAPOLIS (Inside INdiana Business) — Indiana’s life sciences initiative is launching a new competition designed to help solve two health issues facing Hoosiers: diabetes and opioid abuse.

INDIANAPOLIS, Ind - BioCrossroads announces three new members to its Board of Directors. Dr. France Córdova, President of Purdue University, and Dr. Michael McRobbie, President of Indiana University, ...

BioCrossroads Indiana Seed Fund II has made its first two investments: Esanex, a company developing an oncology drug, and Algaeon, which has developed an algae cultivation technology for use in the ...

INDIANAPOLIS (Inside INdiana Business) — An Indiana-born scientist who is credited for his pioneering efforts in echocardiography has been awarded the 2020 August M. Watanabe Life Sciences Champion of ...

BioCrossroads has landed a $2.4 million grant from the Richard M. Fairbanks Foundation. A promotional group for the life sciences in Indiana, BioCrossroads said it will use the grant money to fund ...

BioCrossroads, a public-private initiative in Indiana, said it has launched its second seed fund to support life sciences companies based in that state. The $8.25 million Indiana Seed Fund II is a ...